Overview

A Pilot Study to Assess the Amnesic Properties of Dexmedetomidine in Pediatric Patients

Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
The goal of this study is to determine the effects of dexmedetomidine on memory and recall of children who are receiving dexmedetomidine sedation administered for magnetic resonance imaging (MRI) studies. Dexmedetomidine is currently the standard drug for sedation for diagnostic (MRI, computerized tomography (CT) and Nuclear Medicine) radiological studies at Boston Children's Hospital (BCH). The effect of dexmedetomidine on memory and recall in children has not been studied.
Details
Lead Sponsor:
Boston Children's Hospital
Boston Children’s Hospital
Collaborator:
Memorial Sloan Kettering Cancer Center
Treatments:
Dexmedetomidine